Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum complement proteins in IgA nephropathy.

B A Julian, R J Wyatt, R G McMorrow

    Clinical Nephrology
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Familial IgA nephropathy in southeastern Kentucky.

    Clinical nephrology·2010
    Same author

    Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
    Same author

    Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
    Same author

    Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

    Kidney & blood pressure research·2008
    Same journal

    Clinical characteristics and outcomes of adults with minimal change disease: A retrospective, cross-sectional study.

    Clinical nephrology·2026
    Same journal

    Analysis of end-stage renal disease mediated by cuproptosis-related genes.

    Clinical nephrology·2026
    Same journal

    The relationship between red cell distribution width and platelet ratio in acute kidney injury among ventilator-associated pneumonia patients: A MIMIC-IV database study.

    Clinical nephrology·2026
    Same journal

    Arterial stiffness and choroidal vascularity index in autosomal dominant polycystic kidney disease with preserved kidney function.

    Clinical nephrology·2026
    Same journal

    Antibody-drug conjugate therapy in a renal transplant patient with bladder cancer: A case report.

    Clinical nephrology·2026
    Same journal

    Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model.

    Clinical nephrology·2026
    See all related articles

    In IgA nephropathy patients, higher serum complement levels (C3, B, H, I) correlate with stable kidney function. Complement deficiencies are also observed, suggesting a complex role in disease progression.

    Area of Science:

    • Nephrology
    • Immunology
    • Complement System

    Background:

    • IgA nephropathy is linked to alternative complement pathway activation.
    • Understanding complement's role is crucial for IgA nephropathy progression.
    • Previous studies suggest complement involvement in kidney disease.

    Purpose of the Study:

    • To investigate serum complement components and control proteins in IgA nephropathy patients.
    • To determine the association between complement levels and renal function.
    • To explore the prevalence of complement deficiencies in IgA nephropathy.

    Main Methods:

    • Serum samples from 28 IgA nephropathy patients were analyzed.
    • Complement components (C3, B, H, I) and control proteins were quantified.

    Related Experiment Videos

  • Patients were categorized based on renal function (stable vs. chronic renal failure).

    • Main Results:

    • Patients with chronic renal failure exhibited lower serum C3, B, H, and I levels.
    • Higher serum levels of C3, B, H, and I were associated with stable glomerular filtration rate.
    • Partial familial deficiencies in complement proteins were found in 4 patients.
    • Serum IgA levels and HLA antigen BW35 were not linked to progressive renal insufficiency.

    Conclusions:

    • Elevated serum C3, B, H, and I may indicate preserved renal function in IgA nephropathy.
    • Complement deficiencies occur in IgA nephropathy and warrant further investigation.
    • Serum IgA and BW35 are not reliable markers for progressive renal insufficiency in this condition.